Background: Feeding and swallowing difficulties (FSD) have been found in typically developing children as well as in children with complex medical conditions and developmental disabilities. These difficulties cause negative health consequences such as aspiration pneumonia, chronic lung disease, failure to thrive, prolonged hospital stay and even death. The early identification and management of feeding and swallowing difficulties is important as it prevents the negative effects on health and quality of life. Hence, there is a need for a validated screening tool to use in the general hospitalized paediatric population. Research Aims: The aim of this study was to validate the Feeding and Swallowing Questionnaire as a screening tool, in the paediatric population aged 0 – 2 years admitted to general medical wards. The secondary aim was to describe the FSD presenting in the paediatric population aged 0 - 2 years who are hospitalized in the general medical wards. Methodology: A prospective, descriptive, clinimetric design was utilized. A sample of 107 participants admitted to the general medical wards at Steve Biko Academic Hospital were included in the study. Participants’ feeding and swallowing was screened by a research assistant using the Feeding and Swallowing Questionnaire. After the screening, a clinical feeding and swallowing assessment was conducted for comparison, the assessment was conducted by the student researcher using the Clinical Feeding and Swallowing Assessment Tool. Results: There was a 27% FSD prevalence, with the majority of cases (92%) occurring in children under one year of age. One hundred and three children (63% male; median (IQR) age 5.2 (2.1 – 12.8) months) underwent screening and clinical assessment for feeding and swallowing disorders. The criterion validity of the Feeding and swallowing Questionnaire was established with a sensitivity of 88% and a specificity of 32%. Internal consistency was achieved with an acceptable Cronbach’s alpha of 0.79, and good inter-rater reliability (80%). Participants presented with feeding difficulties in all the phases of swallowing, while some participants had behavioural feeding difficulties. Those who had FSD had the following medical conditions: cardiorespiratory, neurological and gastrointestinal disorders namely acute gastroenteritis and liver disease. Feeding and swallowing difficulties were associated with increased mealtime duration (p=0.005) and supplementary oxygen support (p=0.03). Conclusion: The results confirm that the Feeding and Swallowing Questionnaire shows promising findings as a reliable and valid tool for the identification of FSD in the general hospitalized paediatric population. However, further research in other setting with general paediatric medical wards is required to increase the robustness of the screening tool.

Les entérovirus humains (EV) représentent la première cause des méningites aseptiques chez l'enfant. Le diagnostic de certitude repose sur la détection génomique de l'entérovirus par RT-PCR dans des échantillons de liquide céphalorachidien (LCR) est recommandée pour le diagnostic. La fièvre sans point d'appel et les maladies de type "sepsis" sont également des affections fréquentes chez les nourrissons (0 à 2 ans), qui peuvent être la conséquence d'une infection virale, en particulier à EV. Actuellement, le diagnostic des EV dans le sang est rarement établi dans la pratique courante.Les données concernant 1) l’existence d’une réplication de l’EV dans les leucocytes sanguins, 2) le niveau de charge virale de l’EV dans le sang et les échantillons de LCR et sa corrélation éventuelle avec l’intensité du processus inflammatoire réactionnel sont fragmentaires. Dans la première partie de cette thèse, l'objectif était d'évaluer la détection des EV par PCR dans des échantillons de sang de nouveau-nés, de nourrissons et d'enfants hospitalisés pour une fièvre isolée, un sepsis ou un syndrome méningé. Nous avons mené une étude observationnelle prospective multicentrique nationale (étude BLEDI) dans 35 départements de pédiatrie au cours de la période estivo-automnale (augmentation des circulations d'EV) en 2015-2016. Nos résultats ont montré que le taux de détection des EV dans le sang était significativement plus élevé que dans le LCR chez les nouveaux-nés et les nourrissons hospitalisés pour une fièvre isolée, un sepsis ou un syndrome méningé.Ces données ouvrent des perspectives pour un nouvel algorithme de diagnostic des fièvres inexpliquées chez les enfants âgés de moins de 2 ans. Dans le second volet de cette thèse, nous avons étudié de manière prospective la charge virale d'EV dans le sang et dans des échantillons de LCR de patients infectés. Nos résultats ont montré que la charge virale d'EV dans le sang variait selon le groupe d'âge, la présentation clinique et le type d'EV. Trois profils de cinétique d'infection comparant la charge virale dans le sang et le LCR ont été envisagés et sont en cours d'étude. Enfin, le dernier axe était de déterminer s'il existait une réplication de l’EV dans les leucocytes sanguins. Nous avons montré à partir d'échantillons de sang infectés in vitro par EV que la réplication de ces virus variait selon les génotypes d'EV. / Human enteroviruses (EV) are the most frequent cause of paediatric aseptic meningitis. Detection of enterovirus by PCR in cerebrospinal fluid (CSF) specimens is recommended for diagnosis. Fever without source and sepsis-like diseases are frequent affections in infants (0 to 2 years) which can be the consequence of a viral infection in particular to EV. At present, the daily routin diagnosis of EV in the blood is rarely performed. The concerning data 1) existence of EV replication in the blood leukocytes, 2) the EV viral load level in blood and CSF specimens and its possible relation with the intensity of the associated inflammatory process are fragmented. In the first part of this PhD thesis, the aim was to assess detection of enterovirus by PCR in blood specimens of newbrons, infants, and children with fever without source, sepsis-like disease or suspected meningitis. We did a prospective, multicentre, observational study (BLEDI study) at 35 paediatric departements during the seasonal period of increased EV circulation in 2015-2016. Our results showed that detection of EV was significantly higher in the blood than in the CSF from newborns and infants admitted with fever without source or sepsis-like disease. These data open up the perspectives for a new diagnostic algorithm of febrile illness in patients aged 2 years or younger. We also explored prospectively EV viral load in blood and in CSF specimens of infected patients. Our results showed that EV viral load in the blood varied by age group, clinical presentation and EV type. Three profiles of infection kinetics comparing EV viral load in the blood and the CSF have been considered and are under study. Finally, we explored the hypothesis of an EV replication in the blood leukocytes. We showed from blood samples infected in vitro by EV that the replication of these viruses varied by EV genotypes.

Electrophysiological measures such as impedance telemetry and Neural Response Telemetry (NRT™) were developed by Cochlear™ in 1992 as clinical tools allowing the objective setting of stimulus levels for cochlear implant users. Extensive research proved the usefulness of NRT™’s as an aid in the programming process of audible and comfortable stimulus levels for children younger than six years. The Nucleus® Freedom™, launched in 2005, introduced new developments in cochlear implantation. Approval from the FDA for this system was obtained in March 2005 and for the first time included children from age 12 months with profound hearing loss. The Joint Committee on Infant Hearing suggested that children be diagnosed and that treatment commenced by the age of six months. The new features of the Nucleus Freedom™ give clinicians the necessary tools to treat this challenging population. An urgent need exists to ascertain the stability and accuracy of the new features introduced by this system, especially the Auto-NRT™ software, to validate its use within the paediatric population. A longitudinal descriptive design was utilized implementing quantitative research methods to critically describe the behaviour of impedance telemetry and NRT™’s in a group of young cochlear implant users. The quantitative method included the application of the Custom Sound™ software and the Auto-NRT™ feature for this group at implantation, device activation, and then at determined follow-up visits. Nine young children between nine months and five years and eleven months were used as participants during the twelve months of research. Impedance telemetry was described in terms of the mean Common Ground (CG) and Monopolar 1+2 (MP1+2) values calculated from measurement data collected on the basal, medial, and apical electrodes of the electrode array. The electrodes identified for statistical procedures for both measurement types were E3, E6, E8, E11, E13, E16, E19 and E21. Friedman’s ANOVA was used as a statistical measure to determine the level of significance in changes among the measurement modes and conditions. The Wilcoxon signed-rank test was indicated in the presence of significant changes identified by Friedman’s ANOVA to calculate the level of significance in a pair-wise comparison. Results indicate that impedance telemetry remained consistent over the electrode array and over time in both measurement modes. A slight increase in mean values was observed during the first three months, followed by a gradual decrease at the six months interval. These changes were statistically nonsignificant. No specific trends were evident in impedance telemetry over time. NRT™-measurements remained consistent across the electrode array over time. Significant changes were present between the intra-operative to device activation measurement intervals. This trend is also described in studies of adult cochlear implant users. NRT™-measurements were stable during the first year postimplantation within the paediatric population. A comparison between the mean impedance telemetry and NRT™’s disclosed an inverse trend during the first six months post-implantation. Most changes were non-significant, indicating that these measures can be used effectively in the new semi-automated fitting software. The implementation of these measurements can lead to streamlined and accountable service delivery to young cochlear implant users. AFRIKAANS : In 1992 is elektrofisiologiese metings soos impedanstelemetrie en Neurale Respons Telemetrie (NRT™) deur Cochlear™ ontwikkel as kliniese hulpmiddels om objektiewe instelling van stimulasievlakke vir kogleêre gebruikers moontlik te maak. Navorsing het bewys dat NRT™’s ‘n effektiewe hulpmiddel is tydens programmering van hoorbare en gemaklike stimulasievlakke by kinders jonger as ses jaar. Die Nucleus® Freedom™ met nuwe ontwikkelings ten opsigte van kogleêre inplantings is in 2005 bekendgestel. Die FDA het in Maart 2005 hierdie sisteem goedgekeur vir gebruik by kinders selfs so jonk as 12 maande met uitermatige gehoorverlies. Die Joint Committee on Infant Hearing het voorgestel dat diagnose en aanvang van rehabilitasie teen ses maande ouderdom moet plaasvind. Die nuwe funksies van die Nucleus® Freedom™ stel oudioloë in staat om hierdie uitdagende bevolking te hanteer. ‘n Dringende behoefte bestaan om te bepaal of hierdie sagteware, veral Auto-NRT™ wat saam met hierdie sisteem bekendgestel is, oor voldoende akkuraatheid en stabiliteit beskik om in die hantering van die pediatriese bevolking te gebruik. ‘n Longitudinale, beskrywende ontwerp, wat kwantitatiewe metodes implementeer, is aangewend om die beweging van impedanstelemetrie en NRT™’s by ‘n groep jong gebruikers van kogleêre inplantings krities te beskryf. Dit het die gebruik van die Custom Sound™ sagteware en die ingeslote Auto- NRT™ funksie behels. Dit is tydens inplantering, by aktivering van die toestel, en bepaalde opvolgsessies uitgevoer. Nege jong kinders tussen die ouderdomme van nege maande en vyf jaar en 11 maande is tydens die 12 maande navorsingsperiode as proefpersone benut. Die impedansmetings is beskryf in terme van die Common Ground (CG) en Monopolar 1+2 (MP1+2) stimulasiemodaliteite. Data is verkry vanaf geselekteerde elektrodes op die basale, mediale en apikale gedeeltes van die elektrode. Vir statistiese ontledings van impedans en NRT™ is hierdie elektrodes geselekteer: E3, E6, E8, E11, E13 E16, E19 en E21. As statistiese ontledingsmetode, is Friedman se ANOVA toegepas om die vlakke van beduidenheid van beweging tussen die verskillende toetsmodaliteite en -omstandighede te bepaal. Die Wilcoxon signed-rank toets is aangedui in die teenwoordigheid van statisties beduidende veranderinge. Die doel van hierdie toets was om die vlak van beduidenheid paarsgewys te verifieer. Resultate dui op konstante impedansmetings oor die elektrode asook oor tyd in beide toetsmodaliteite. ‘n Geringe, statisties nie-beduidende, verhoging in gemiddelde waardes is waargeneem tydens die eerste drie maande na inplantering, waarna die waardes weer geleidelik afgeneem het tot en met die ses maande opvolginterval. Geen spesifieke neiging kon vir impedanstelemetrie bepaal word nie. NRT™-metings het konstant gebly oor die elektrode en met tyd. Statisties beduidende veranderinge is gemeet tussen die intra-operatiewe en aktiveringsintervalle. Hierdie neiging is ook beskryf in studies van volwasse gebruikers van kogleêre inplantings. NRT™-metings, binne die pediatriese populasie, het dus stabiel gebly oor die 12 maande periode post-inplantering. ‘n Vergelyking tussen die gemiddelde impedans- en NRT™-metings het ‘n inverse neiging geïdentifiseer gedurende die eerste ses maande na inplantering. Veranderinge was oor die algemeen statisties nie-beduidend, wat daarop dui dat hierdie metings effektief gebruik kan word. Die implementering van hierdie metings kan meer doeltreffende dienslewering aan die jong gebruikers van kogleêre inplantings tot gevolg hê. / Dissertation (MCommunication Pathology)--University of Pretoria, 2010. / Speech-Language Pathology and Audiology / unrestricted